VSEs™ unlock the potential of your Cell & Gene Therapy
Virica was founded in 2018 based on a decade of research in the laboratory of Dr. Jean-Simon Diallo at the Ottawa Hospital Research Institute.
We pioneered a new product category of Viral Sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. Customized VSE formulations optimize research processes and enhance production. VSE™ help bring your treatments to patients on an accelerated timeline.
Our purpose is to realize the promise of viral medicines, thereby extending the horizons of human healthcare.